Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Roll

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Deutsches Arzteblatt International|December 17, 2025
Abdominal Compartment Syndrome in Rapidly Progressive Lymphoproliferative Disorder Following Kidney TransplantationAmélie Friederike Menke, Stefan Reuter, Wolfgang Roll
Nuklearmedizin. Nuclear Medicine|October 23, 2023
The value of core needle biopsy in the diagnostic workup of a [18F]FDG-PET positive thyroid metastasis from colorectal cancerPhilipp Rassek, Stefanie Bobe, Peter Kies, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 2, 2023
Infection Imaging: Focus on New Tracers?Wolfgang Roll, Andreas Faust, Sven Hermann, et al.
Clinical Nuclear Medicine|July 31, 2018
177Lu-DOTATATE Therapy in Radioiodine-refractory Differentiated Thyroid Cancer: A Single Center ExperienceWolfgang Roll, Burkhard Riemann, Michael Schäfers, et al.
Clinical Nuclear Medicine|December 7, 2016
Excellent Response to 177Lu-PSMA-617 Radioligand Therapy in a Patient With Advanced Metastatic Castration Resistant Prostate Cancer Evaluated by 68Ga-PSMA PET/CTWolfgang Roll, Axel Bode, Matthias Weckesser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 27, 2021
Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: implications for patient managementWolfgang Roll, Matthias Weckesser, Robert Seifert, et al.
Clinical Nuclear Medicine|July 24, 2018
Long-term Survival and Excellent Response to Repeated 177Lu-Prostate-Specific Membrane Antigen 617 Radioligand Therapy in a Patient With Advanced Metastatic Castration-Resistant Prostate CancerWolfgang Roll, Axel Bräuer, Matthias Weckesser, et al.
Clinical Nuclear Medicine|October 26, 2023
177 Lu-DOTATATE (Lutathera) Therapy in 68 Ga-DOTATATE PET/CT-Negative Liver Metastases of a Neuroendocrine TumorDavid Ventura, Wolfgang Roll, Hans-Udo Kasper, et al.
Current Opinion in Urology|May 6, 2025
Toxicities of radioligand and radioisotope therapy in prostate cancer: a systematic review and meta-analysisDavid Ventura, Benjamin Noto, Nadir Rodriguez Jauregui, et al.
Clinical Nuclear Medicine|February 22, 2018
99mTc-MDP SPECT-CT and Ultrasound in the Diagnosis and Staging of Thyroid Metastasis From OsteosarcomaWolfgang Roll, Matthias Weckesser, Monika Pöppelmann, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Deutsches Arzteblatt International|December 17, 2025
Abdominal Compartment Syndrome in Rapidly Progressive Lymphoproliferative Disorder Following Kidney TransplantationAmélie Friederike Menke, Stefan Reuter, Wolfgang Roll
Nuklearmedizin. Nuclear Medicine|October 23, 2023
The value of core needle biopsy in the diagnostic workup of a [18F]FDG-PET positive thyroid metastasis from colorectal cancerPhilipp Rassek, Stefanie Bobe, Peter Kies, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 2, 2023
Infection Imaging: Focus on New Tracers?Wolfgang Roll, Andreas Faust, Sven Hermann, et al.
Clinical Nuclear Medicine|July 31, 2018
177Lu-DOTATATE Therapy in Radioiodine-refractory Differentiated Thyroid Cancer: A Single Center ExperienceWolfgang Roll, Burkhard Riemann, Michael Schäfers, et al.
Clinical Nuclear Medicine|December 7, 2016
Excellent Response to 177Lu-PSMA-617 Radioligand Therapy in a Patient With Advanced Metastatic Castration Resistant Prostate Cancer Evaluated by 68Ga-PSMA PET/CTWolfgang Roll, Axel Bode, Matthias Weckesser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 27, 2021
Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: implications for patient managementWolfgang Roll, Matthias Weckesser, Robert Seifert, et al.
Clinical Nuclear Medicine|July 24, 2018
Long-term Survival and Excellent Response to Repeated 177Lu-Prostate-Specific Membrane Antigen 617 Radioligand Therapy in a Patient With Advanced Metastatic Castration-Resistant Prostate CancerWolfgang Roll, Axel Bräuer, Matthias Weckesser, et al.
Clinical Nuclear Medicine|October 26, 2023
177 Lu-DOTATATE (Lutathera) Therapy in 68 Ga-DOTATATE PET/CT-Negative Liver Metastases of a Neuroendocrine TumorDavid Ventura, Wolfgang Roll, Hans-Udo Kasper, et al.
Current Opinion in Urology|May 6, 2025
Toxicities of radioligand and radioisotope therapy in prostate cancer: a systematic review and meta-analysisDavid Ventura, Benjamin Noto, Nadir Rodriguez Jauregui, et al.
Clinical Nuclear Medicine|February 22, 2018
99mTc-MDP SPECT-CT and Ultrasound in the Diagnosis and Staging of Thyroid Metastasis From OsteosarcomaWolfgang Roll, Matthias Weckesser, Monika Pöppelmann, et al.
Pageof 6